Company / Assets per Share
FATE THERAPEUTICS INC Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$2.80
FY2025
5-year range
$2.80 / $10.50
FY2021-FY2025
Trend
-37.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $10.50 in FY2021 to $2.80 in FY2025.
Based on SEC 10-K filings.
2.80 in FY2025 with a 5-year CAGR of -19.4%.
Declined from $5.20 to $2.80 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -27.6%
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 37.3% year-over-year.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.80 | -37.3% |
| FY2024 | $4.47 | -14.1% |
| FY2023 | $5.20 | -29.4% |
| FY2022 | $7.37 | -29.8% |
| FY2021 | $10.50 | +27.8% |
| FY2020 | $8.22 | +75.9% |
| FY2019 | $4.67 | +15.5% |
| FY2018 | $4.05 | +59.0% |
| FY2017 | $2.54 | -23.1% |
| FY2016 | $3.31 | +0.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026